OR WAIT null SECS
December 02, 2022
The European Human Medicines Directive and Regulation is due to be updated by the end of 2022, but what changes are on the cards?
Anti-obesity drugs have the potential to be the next blockbusters, according to market analysis.
December 01, 2022
Catalent has completed the expansion of its clinical supply facility located in Shanghai, China.
Results from Eisai and Biogen’s Alzheimer's treatment, lecanemab, indicated significantly slowed cognitive decline in patients relative to placebo.
Merck will use BigHat’s AI/machine learning-enabled platform to design candidates for up to three drug discovery programs.
November 30, 2022
AstraZeneca inked a deal worth up to $320 million to purchase Neogene Therapeutics, a biotech start-up focused on T-cell receptor therapies.
The agreement will see Immutep and Merck KGaA, Darmstadt, Germany jointly fund the INSIGHT-005 study.
Aptamer’s new 18,000 ft² facility will expand the company's capacity to deliver novel binders for bioprocessing, diagnostic, and drug development.
Etihad Cargo is one of the only airlines to hold IATA CEIV Pharma certification globally.
November 29, 2022
The decision to move forward in Phase III development stems from the threat of resistance to current malaria treatment growth.